可吸收的静血剂模仿Gossypiboma或感染收集在成像上的成像
Kirti Anna Koikkara1, Joseph Chacko Paul1, Vineeth Joseph Abraham1
1Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India.
The Indian journal of radiology & imaging
|December 19, 2024
概括
可吸收的静血剂可以模仿严重的疾病,如gossypiboma或成像上的感染. 了解它们的外观对于准确诊断和避免临床实践中误解至关重要.
科学领域:
- 放射学 放射学是指放射学
- 医疗成像医学成像
- 手术用材料 手术用材料
背景情况:
- 可吸收的静血剂经常在手术中使用.
- 这些药物的特征性成像外观并未得到广泛认可.
- 错误识别可能会导致重大临床和医疗法律问题.
研究的目的:
- 为了划分可吸收的静血剂的成像特征.
- 为了将这些特征与潜在的成像模拟进行比较.
- 提供有关该主题的文献评论.
主要方法:
- 案例系列分析.
- 图像检查结果的审查.
- 与已知的疾病比较,如gossypiboma和受感染的收藏.
主要成果:
- 可吸收的静血剂可以呈现出类似其他病理的成像特征.
- 确定了与这些药物相关的特定成像模式.
- 突出了不同的诊断考虑因素.
结论:
- 对放射科医生来说,熟悉可吸收血静剂的成像外观是必不可少的.
- 将这些药物与像gossypiboma或这样的模仿药物区分开来,可以提高诊断的准确性.
- 这些知识有助于适当的患者管理,并减少潜在的医疗法律并发症.
相关概念视频
Introduction to Hemostasis
5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
4.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K


